Katherine Bach Kalin

Insider Reports History

Location
Cleveland, OH
Signature
/s/ Daniel Bagliebter, Power of Attorney for: Katherine Bach Kalin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katherine Bach Kalin:

Company Role Class Num Shares Value Price $ Report Date Ownership
SELLAS Life Sciences Group, Inc. Director Common Stock 154,400 $581,995 $3.77 07 Jan 2026 Direct
ATHERSYS, INC / NEW Director NonQualified Stock Option (right to purchase) 50,000 15 Jun 2021 Direct
SELLAS Life Sciences Group, Inc. Director Stock Option (Right to Buy) 18,500 10 Jan 2025 Direct

Insider Reports Filed by Katherine Bach Kalin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLS SELLAS Life Sciences Group, Inc. 07 Jan 2026 1 $0 4 Director 09 Jan 2026, 16:31
SLS SELLAS Life Sciences Group, Inc. 19 Nov 2025 1 +$100,806 4 Director 21 Nov 2025, 08:45
SLS SELLAS Life Sciences Group, Inc. 22 May 2025 1 +$36,000 4 Director 22 May 2025, 16:05
SLS SELLAS Life Sciences Group, Inc. 10 Jan 2025 2 $0 4 Director 14 Jan 2025, 17:31
SLS SELLAS Life Sciences Group, Inc. 22 Jan 2024 2 $0 4 Director 25 Jan 2024, 06:03
SLS SELLAS Life Sciences Group, Inc. 02 Feb 2023 2 $0 4 Director 03 Feb 2023, 16:10
SLS SELLAS Life Sciences Group, Inc. 13 Aug 2022 1 $0 4 Director 16 Aug 2022, 16:08
SLS SELLAS Life Sciences Group, Inc. 13 Aug 2022 0 $0 3 Director 16 Aug 2022, 16:07
/report/000136814821000078-kalin-katherine-bach-2021-06-15 ATHERSYS, INC / NEW 15 Jun 2021 1 $0 4 Director 15 Jun 2021, 17:56